Ironwood Pharmaceuticals IRWD Net debt / EBITDA
Net debt / EBITDA at other companies
Other financials
Where this comes from
Calculated from Ironwood Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The official record: Ironwood Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Ironwood Pharmaceuticals's net debt / ebitda.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Ironwood Pharmaceuticals's net debt / EBITDA?
- Ironwood Pharmaceuticals (IRWD) reported net debt / EBITDA of -0× in Q1 2026.
- How has Ironwood Pharmaceuticals's net debt / EBITDA changed year-over-year?
- Ironwood Pharmaceuticals's net debt / EBITDA increased by 97.7% year-over-year, from -1.7× to -0×.
- What is the long-term trend for Ironwood Pharmaceuticals's net debt / EBITDA?
- Over 4 years (2020 to 2025), Ironwood Pharmaceuticals's net debt / EBITDA has grown at a -67.3% compound annual growth rate (CAGR), from -2.3× to -0×.
- What does net debt / EBITDA mean?
- Net debt (total debt minus cash) divided by trailing-twelve-month EBITDA. Expresses leverage in years — roughly how long it would take to repay net debt out of operating cash earnings.